Outcomes of transperineal template-guided prostate biopsy in 409 patients

BJU International

Volumn 112, Issue 5, 2013, Pages 585-593

  Symons, James L ^a,b   Huo, Andrew ^a   Yuen, Carlo L ^c,d   Haynes, Anne Maree ^a   Matthews, Jayne ^b   Sutherland, Robert L ^a   Brenner, Phillip ^c,d   Stricker, Phillip D ^b,c,d  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b St Vincent's Prostate Cancer Centre   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ST VINCENT'S CLINIC   (Australia)

Author keywords

ESBL; extended spectrum beta lactamase; infection; prostate biopsy; prostate cancer; transperineal

Indexed keywords

ANTIBIOTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; DIGITAL RECTAL EXAMINATION; DYSURIA; FEVER; FOLLOW UP; GLEASON SCORE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; REPEAT PROCEDURE; SEPTICEMIA; TRANSPERINEAL TEMPLATE GUIDED PROSTATE BIOPSY; URINARY TRACT INFECTION; URINE RETENTION;

ESBL; EXTENDED-SPECTRUM BETA-LACTAMASE; INFECTION; PROSTATE BIOPSY; PROSTATE CANCER; TRANSPERINEAL;

AGED; AMBULATORY SURGICAL PROCEDURES; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PERINEUM; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RECTAL DISEASES; RECTUM;

EID: 84882288533     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11657.x     Document Type: Article

References (46)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA,. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-74; discussion 74-5
2. Eskew LA, Bare RL, McCullough DL,. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-202; discussion 202-3
3. Presti JC, Chang JJ, Bhargava V, Shinohara K,. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163: 163-166; discussion 166-7
4. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR,. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 1998; 159: 1247-1250
5. Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152-157
6. Noguchi M, Matsuoka K, Koga H, Kanetake H, Nakagawa M, Naito S,. A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan. Int J Clin Oncol 2006; 11: 390-395
7. Shandera KC, Thibault GP, Deshon GE,. Variability in patient preparation for prostate biopsy among American urologists. Urology 1998; 52: 644-646
8. Galfano A, Novara G, Iafrate M, et al. Prostate Biopsy: the Transperineal Approach. EAU-EBU Update Series 2007; 5: 241-249
9. Stevens MJ, Stricker PD, Saalfeld J, et al. Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience. Australas Radiol 2003; 47: 152-160
10. USANZ. Prostate Biopsy Audit Report. Edgecliff: Urological Society of Australia and New Zealand, 2005
11. USANZ. Prostate Biopsy Audit Report. Edgecliff: Urological Society of Australia and New Zealand, 2007
12. Emiliozzi P, Scarpone P, DePaula F, et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol 2004; 171: 197-199
13. Vis AN, Boerma MO, Ciatto S, Hoedemaeker RF, Schröder FH, van der, Kwast TH,. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy. Urology 2000; 56: 617-621
14. Demura T, Hioka T, Furuno T, et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 2005; 103: 1826-1832
15. Kawakami S, Kihara K, Fujii Y, Masuda H, Kobayashi T, Kageyama Y,. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int J Urol 2004; 11: 613-618
16. Furuno T, Demura T, Kaneta T, et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 2004; 58: 76-81
17. Satoh T, Matsumoto K, Fujita T, et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005; 66: 114-118
18. Chen ME, Troncoso P, Johnston D, Tang K, Babaian RJ,. Prostate cancer detection: relationship to prostate size. Urology 1999; 53: 764-768
19. Raaijmakers R, Kirkels W, Roobol M, Wildhagen M, Schrder F,. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-830
20. Berger AP, Gozzi C, Steiner H, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004; 171: 1478-1480; discussion 1480-1
21. Kawakami S, Yamamoto S, Numao N, Ishikawa Y, Kihara K, Fukui I,. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 2007; 14: 719-724
22. Dindo D, Demartines N, Clavien P-A,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
23. Yuasa T, Tsuchiya N, Kumazawa T, et al. Characterization of prostate cancer detected at repeat biopsy. BMC Urol 2008; 8: 14
24. Rabets JC, Jones JS, Patel A, Zippe CD,. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 2004; 172: 94-97
25. Taira AV, Merrick GS, Galbreath RW, et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010; 13: 71-77
26. Thompson IM, Leach RJ, Ankerst DP,. Prostate Cancer Detection: a View of the Future. Eur Urol 2011; 59: 191-193
27. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952-955; discussion 955
28. Kim SJ, Kim SI, Ahn HS, Choi JB, Kim YS, Kim SJ,. Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean J Urol 2010; 51: 426-430
29. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-131
30. Miura T, Tanaka K, Shigemura K, Nakano Y, Takenaka A, Fujisawa M,. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Int J Urol 2008; 15: 457-459
31. Young JL, Liss MA, Szabo RJ,. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 2009; 74: 332-338
32. Cullen IM, Manecksha RP, McCullagh E, et al. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU Int 2012; 109: 1198-1206
33. Paterson DL, Bonomo RA,. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686
34. Cannon GM, Smaldone MC, Paterson DL,. Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. Can J Urol 2007; 14: 3653-3655
35. Duplessis CA, Bavaro M, Simons MP, et al. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 2012; 79: 556-561
36. Merrick GS, Gutman S, Andreini H, et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 2007; 52: 715-723
37. Brawer MK,. The Influence of Prostate Volume on Prostate Cancer Detection. Eur Urol Suppl 2002; 11: 35-39
38. Pepe P, Aragona F,. Prostate needle biopsy: 12 vs. 18 cores-is it necessary? Urol Int 2005; 74: 19-22
39. Ficarra V, Novella G, Novara G, et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol 2005; 48: 932-937
40. Cohen RJ, Shannon BA, Phillips M, Moorin RE, Wheeler TM, Garrett KL,. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol 2008; 179: 1762-1767
41. Shannon BA, Mc Neal JE, Cohen RJ,. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathology 2003; 35: 467-471
42. McNeal JE, Bostwick DG,. Anatomy of the Prostate: Implication for Disease. New York: Churchill-Livingstone, 1990
43. Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V,. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 2003; 61: 961-966
44. Kawakami S, Hyochi N, Yonese J, et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol 2006; 11: 127-132
45. Watanabe M, Hayashi T, Tsushima T, Irie S, Kaneshige T, Kumon H,. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol 2005; 12: 959-963
46. Barzell WE, Melamed MR,. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urology 2007; 70: 27-35